You are in: eMedicine Specialties >
Sports Medicine > Foot and Ankle
Metatarsal Stress Fracture
Article Last Updated: Sep 26, 2007
AUTHOR AND EDITOR INFORMATION
Section 1 of 12
Author: Andrew D Perron, MD, Residency Director, Department of Emergency Medicine, Maine Medical Center
Andrew D Perron is a member of the following medical societies: American College of Emergency Physicians, American College of Sports Medicine, and Society for Academic Emergency Medicine
Editors: Anthony J Saglimbeni, MD, Staff Physician, Family Practice Residency, Medical Director, Center for Sports Medicine, O'Connor Hospital; Private Practice; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Russell D White, MD, Professor of Medicine, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood; Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital; Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago
Author and Editor Disclosure
Synonyms and related keywords:
march fracture, stress fracture of the metatarsals, foot fracture, foot stress fracture, broken foot, fractured foot, female athlete triad, Breithaupt fracture
Background
With an increase in public interest in physical fitness, clinical practitioners are diagnosing stress fractures with greater frequency.1 First described by Aristotle in 200 BC, stress fractures were initially recorded in the medical literature in 1855 by the Prussian military physician Breithaupt, who described what is now known as a march fracture, or stress fracture of the metatarsals. Metatarsal stress fractures are not limited to high-level athletes or military recruits. This type of injury is seen in runners of all levels, as well as ballet dancers and gymnasts and patients with rheumatoid arthritis (RA), metabolic bone disease, and neuropathic conditions.2 Metatarsal stress fractures are also seen with increasing frequency in patients who engage in aerobics activities, particularly high-impact aerobics.
Frequency
United States
The incidence of stress fractures in the general population is unknown, as virtually all literature on the subject is derived from a military population or advanced-level athletes. Stress fractures are estimated to constitute up to 16% of all injuries that are related to athletic participation; running is the cause in most of these cases. Most stress fractures (95%) involve the lower extremities, particularly the metatarsals.
Functional Anatomy
The second and third metatarsals are relatively fixed in position within the foot; the first, fourth, and fifth metatarsals are relatively mobile. More stress is placed on the second and third metatarsals during ambulation; thus, these bones are at increased risk for stress fractures. The fifth metatarsal, which is approximately 1.5 cm from the proximal pole of the bone, bears greater stress in those who oversupinate when they walk or run. The fifth metatarsal also has a diminished blood supply and, thus, a decreased ability to heal. Stress fractures of the proximal fifth metatarsal must be distinguished from proximal avulsion fractures ("pseudo-Jones" fractures) and Jones fractures. The proximal avulsion fracture is usually associated with a lateral ankle strain and occurs at the insertion of the peroneus brevis tendon. The true Jones fracture is an acute fracture of the proximal diametaphyseal junction.
History
- Patients usually report having increased the intensity or duration of their exercise regimen.
- Initially, dull pain only occurs with exercise, then the condition progresses to pain at rest.
- Pain starts diffusely, then localizes to the site of the fracture.
- Stress fractures can be historically distinguished from a true Jones fracture, because patients with a stress mechanism as the etiology report a long history of prodromal symptoms of pain over the proximal fifth metatarsal.
- Menstrual irregularities should be explored in female patients due to a high association between female athletics, amenorrhea, and osteoporosis—otherwise known as the female athletic triad.3, 4
Physical
- Inspect the affected foot for swelling, bruising, or warmth.
- Inspect both feet for a side-by-side comparison.
- Palpate the affected foot to find the point of maximal tenderness. Specifically seek to determine if the point of maximal tenderness is related to bony or soft-tissue problems.
- Inspect the patient's athletic shoes for signs of excessive supination or excessive wear under the metatarsal heads.
Causes
- Increased intensity, duration, or frequency of exercise
- New footwear
- Insufficient rest periods
- Continuing to train despite pain
- Osteopenia/osteoporosis
- Rheumatoid arthritis
- Neuropathic foot
- Female athletic triad
Metatarsalgia
Morton Neuroma
Turf Toe
Other Problems to Be Considered
Acute metatarsal fracture Hallux rigidus Jones fracture Sesamoid stress fracture Acute sesamoid fracture Proximal fifth-metatarsal avulsion fracture (pseudo-Jones fracture)
Lab Studies
- Due to a known association between RA and stress fractures, the clinician may consider a workup for RA, with an erythrocyte sedimentation rate (ESR) and rheumatoid panel. This workup is not routine in most patients, but it is a consideration when the clinical picture is unclear or indicates the possibility of RA.
- A workup for osteoporosis may be considered, especially in oligomenorrheic females and in patients who have (or have had) multiple stress fractures.
Imaging Studies
- Plain-film radiography
- Radiographs may be negative early in the process.3, 5
- Stress-fracture changes may not be evident on plain films until 3 months after the onset of symptom(s).
- Up to 50% of stress fractures are never observed on plain films.
- Plain-film radiographs can help the physician distinguish fifth-metatarsal stress fractures from true Jones fractures. Fractures with a stress etiology show a widened fracture line, intramedullary sclerosis, and periosteal reaction.
- Bone scanning6, 7
- Technetium-99 (99mTc) diphosphonate 3-phase bone scanning has traditionally been the imaging modality of choice.
- Bone scanning is nearly 100% sensitive for the diagnosis of stress fractures, although the specificity of this modality is considerably lower.
- Bone scans can demonstrate stress fractures within 24-72 hours from the onset of symptom(s).
- Differentiation between stress fractures and stress reactions may be determined with a bone scan.
- Magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT)8, 9, 10: These modalities may also be used to image stress fractures; however, MRI has become the study of choice because it has the same sensitivity as a bone scan but with a much higher specificity. Additionally, MRI does not require ionizing radiation.
Acute Phase
Rehabilitation Program
Physical Therapy
The patient should rest from the offending activity. Immobilization is recommended for comfort, with use of a postoperative (wooden-soled) shoe or short CAM Walker (Bird and Cronin, Inc, Eagan, Minn). It is important to apply ice and elevate the foot to minimize pain and swelling. If there is marked pain or minimal evidence of healing for stress fractures of the second or third metatarsals, a short-leg walking cast can be used until there is radiographic evidence of healing.
Recreational Therapy
During the respite period from the offending activity, the patient may maintain fitness by cycling, aqua-running, or resistance training by using equipment that does not involve the affected area.
Surgical Intervention
Stress fractures of the second or third metatarsals rarely require surgical intervention. Most of these fractures heal uneventfully, and nonunion is rare. However, stress fractures of the fifth-metatarsal base are more problematic. Displacement of these fractures tends to increase with continued weight bearing. The treatment options are 2-fold as follows: - Less-active patients should be non-weight bearing in a short-leg cast for 6-8 weeks or until there is radiographic evidence of healing. If an established nonunion develops, screw fixation and/or bone grafting may be required.11
- For active patients, early intramedullary screw fixation, with or without bone grafting, is often recommended.
Consultations
Consult an orthopedic surgeon for fifth-metatarsal fractures or for second- or third-metatarsal fractures that do not demonstrate radiographic healing after 6 weeks.
Recovery Phase
Rehabilitation Program
Physical Therapy
During the recovery phase, the patient may progress to weight bearing as tolerated, initially in a wooden-soled shoe, and then in a comfortable shoe.
Recreational Therapy
Aqua-running, swimming, or bicycling may be continued to maintain physical fitness.
Maintenance Phase
Rehabilitation Program
Physical Therapy
The patient may be allowed to gradually return to his or her sport with a slow build-up in intensity and duration, with regular rest intervals. No more than a 10% increase in intensity or duration should be allowed from week to week. Any pain recurrence should prompt a rest period, followed by resuming the activity at a lower level.
Recreational Therapy
The patient may resume running with a slow increase in duration and intensity of the workouts (ie, no more than a 10% increase in intensity or duration per week).
Surgical Intervention
Patients who continue to have painful nonunion fractures are candidates for surgical intervention.11 A fibrous nonunion that is not painful and does not limit the patient's functional abilities may be left alone.
Consultations
An orthopedic surgeon should be consulted in cases in which there is radiographic evidence of nonunion or prolonged pain.
Analgesics may be needed in the acute phase of the treatment for metatarsal stress fractures. The patient often encounters mild to moderate pain until a period of rest and/or immobilization has occurred.
Drug Category: Nonsteroidal anti-inflammatory drugs
These agents have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but these drugs may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell membrane functions.
| Drug Name | Ibuprofen (Advil, Motrin) |
| Description | DOC for mild to moderate pain, if there are no contraindications. Ibuprofen inhibits inflammatory reactions and pain by inhibiting the activity of cyclooxygenase, which reduces prostaglandin synthesis. |
| Adult Dose | 200-800 mg PO q6-8h; not to exceed 3.2 g/d |
| Pediatric Dose | <6 months: Not established 6 months to 12 years: 20-40 mg/kg/d PO divided q6h >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity to ibuprofen, other NSAIDs, or aspirin; avoid in peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, and high risk of bleeding |
| Interactions | May decrease effects of loop diuretics with coadministration; coadministration with anticoagulants may increase PT duration (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate toxicity; probenecid may increase toxicity of NSAIDs |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
|
| Precautions | Caution in patients who have congestive heart failure, hypertension, and decreased renal and hepatic function; caution in patients with anticoagulation abnormalities or during anticoagulant therapy |
| Drug Name | Ketoprofen (Orudis, Actron, Oruvail) |
| Description | For relief of mild to moderate pain and inflammation. Small dosages are indicated initially in patients with small body size, elderly patients, and those with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe patient for response. |
| Adult Dose | 25 to 50 mg PO q6-8h prn; not to exceed 300 mg/d |
| Pediatric Dose | <3 months: Not established 3 months to 12 years: 0.1-1 mg/kg PO q6-8h >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | May decrease effects of loop diuretics with coadministration; coadministration with anticoagulants may increase PT duration (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate and phenytoin toxicity; probenecid may increase toxicity of NSAIDs |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
|
| Precautions | Caution in patients who have congestive heart failure, hypertension, and decreased renal and hepatic function; caution in patients with anticoagulation abnormalities or during anticoagulant therapy |
| Drug Name | Naproxen (Aleve, Naprelan, Naprosyn, Anaprox) |
| Description | For relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which is responsible for prostaglandin synthesis. |
| Adult Dose | 500 mg PO, followed by 250 mg q6-8h; not to exceed 1.25 g/d |
| Pediatric Dose | <2 years: Not established >2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency |
| Interactions | Probenecid may increase toxicity of NSAIDs; coadministration with ibuprofen may decrease effects of loop diuretics; coadministration with anticoagulants may increase PT duration (watch for signs of bleeding); NSAIDs may increase serum lithium levels and risk of methotrexate toxicity (eg, stomatitis, bone marrow suppression, nephrotoxicity) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
|
| Precautions | Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion, risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrant further evaluation and may require discontinuation of drug |
| Drug Name | Flurbiprofen (Ansaid) |
| Description | May inhibit cyclooxygenase enzyme, which in turn inhibits prostaglandin biosynthesis. These effects may result in analgesic, antipyretic, and anti-inflammatory activities. |
| Adult Dose | 200-300 mg/d PO divided bid/qid |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | May decrease effects of loop diuretics with coadministration; coadministration with anticoagulants may increase PT duration (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate toxicity; probenecid may increase toxicity of NSAIDs |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
|
| Precautions | May decrease effects of loop diuretics with coadministration; coadministration with anticoagulants may increase PT duration (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate toxicity; probenecid may increase toxicity of NSAIDs |
Drug Category: Analgesics
Pain control is essential for quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and have sedating properties, which are beneficial for patients who have sustained trauma or injuries.
| Drug Name | Acetaminophen (Tylenol, Panadol, Paracetamol) |
| Description | DOC for pain in patients with documented hypersensitivity to aspirin, NSAIDs, diagnosed with upper GI disease or on oral anticoagulants. |
| Adult Dose | 325-650 mg PO q4-6h or 1000 mg tid/qid; not to exceed 4 g/d |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d >12 years: 325-650 mg PO q4h; not to exceed 5 doses in 24 h |
| Contraindications | Documented hypersensitivity; known G6PD deficiency |
| Interactions | Coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
|
| Precautions | Rifampin can reduce analgesic effects of acetaminophen |
| Drug Name | Hydrocodone bitartrate with acetaminophen (Vicodin, Lortab, Lorcet HD) |
| Description | Drug combination indicated for moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn pain |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d >12 years: 750 mg PO q4h; not to exceed 10 mg hydrocodone bitartrate per dose or 5 doses/24h |
| Contraindications | Documented hypersensitivity to acetaminophen or hydrocodone; high altitude cerebral edema (HACE) or elevated intracranial pressure (ICP) |
| Interactions | Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
|
| Precautions | Tablets contain metabisulfite which may cause hypersensitivity; caution in patients who are dependent on opiates since this substitution may result in acute opiate withdrawal symptoms; caution in patients with severe renal or hepatic dysfunction |
| Drug Name | Propoxyphene and acetaminophen (Darvocet-N 100, Wygesic) |
| Description | Drug combination indicated for mild to moderate pain. |
| Adult Dose | 1-2 tab PO q4h prn; not to exceed 600 mg/d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase serum concentrations of MAO inhibitors, tricyclic antidepressants, carbamazepine, phenobarbital, and warfarin |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
|
| Precautions | Caution in patients who are dependent on opiates, as substitution may result in acute opiate withdrawal symptoms; caution in patients with severe renal or hepatic dysfunction |
Return to Play
- After recovery from metatarsal stress fractures, patients may return to play when they can participate without pain.
- The intensity and duration of activities need to be increased slowly, and the patient must adhere to regular rest periods.
Complications
- Nonunion is the primary complication of metatarsal stress fractures.
- Nonunion rates of 35-50% in fifth-metatarsal stress fractures are reported in the literature. For other metatarsal stress fractures, the nonunion rate is low.
Prevention
- Increases in sports-training demands, whether in intensity or duration, should be performed in a slow cyclical manner, and rest periods need to be built into training regimens. Use of orthotics has not been proven to decrease the incidence of metatarsal stress fractures.
- Athletes who develop pain during exercise need to decrease their training level to one that is painless, and then they can slowly resume a training regimen.
- Physicians, coaches, trainers, and parents need to be aware of metatarsal stress fractures and the symptoms. Prompt treatment can reduce morbidity and time lost from the offending sport or activity.
Prognosis
- Stress fractures in the first 4 metatarsals routinely heal without complication.
- Stress fractures at the base of the fifth metatarsal have a nonunion rate of 35-50%.
Education
- The key to preventing stress fractures lies in the education of athletes, parents, coaches, trainers, and doctors.
- Properly selected and fitted equipment, particularly running shoes, is important in deterrence of metatarsal stress fractures.
- Training needs to be performed in a slow cyclical progression that allows the body to adapt. Adequate rest and recovery time needs to be incorporated into the participant's training regimen.
- The quality of physical activity, rather than quantity, should be stressed in any exercise program.
- The athlete, coach, trainer, and physician must recognize that exercise regimens are not "one size fits all." Tailor the training to the participant's baseline ability, previous experience, and current level of physical activity.
For excellent patient education resources, visit eMedicine's Breaks, Fractures, and Dislocations Center and Sports Injury Center. Also, see eMedicine's patient education article Broken Foot.
Medical/Legal Pitfalls
- Failure to consider the diagnosis of metatarsal stress fracture
- Failure to pursue the diagnosis if plain films are negative
- Failure to refer patients with fifth-metatarsal stress fractures to an orthopedic specialist
Gehrmann RM, Renard RL. Current concepts review: stress fractures of the foot. Foot Ankle Int. Sep 2006;27(9):750-7. [Medline].
| Media file 1:
Radiograph of the feet. This image depicts a stress fracture of the left second metatarsal with exuberant callus. |
 | View Full Size Image | |
Media type: X-RAY
|
| Media file 2:
Radiograph of the left foot. This image depicts a stress fracture of the fifth metatarsal. |
 | View Full Size Image | |
Media type: X-RAY
|
| Media file 3:
Bone scan of the lower extremities. This image depicts a right fifth metatarsal stress fracture. |
 | View Full Size Image | |
Media type: Nuclear Image
|
- Maitra RS, Johnson DL. Stress fractures. Clinical history and physical examination. Clin Sports Med. Apr 1997;16(2):259-74. [Medline].
- Hockenbury RT. Forefoot problems in athletes. Med Sci Sports Exerc. Jul 1999;31(7 suppl):S448-58. [Medline].
- Reeder MT, Dick BH, Atkins JK, Pribis AB, Martinez JM. Stress fractures. Current concepts of diagnosis and treatment. Sports Med. Sep 1996;22(3):198-212. [Medline].
- Brukner P, Bennell K. Stress fractures in female athletes. Diagnosis, management and rehabilitation. Sports Med. Dec 1997;24(6):419-29. [Medline].
- Sallis RE, Jones K. Stress fractures in athletes. How to spot this underdiagnosed injury. Postgrad Med. May 1 1991;89(6):185-8, 191-2. [Medline].
- Matheson GO, Clement DB, McKenzie DC, et al. Stress fractures in athletes. A study of 320 cases. Am J Sports Med. Jan-Feb 1987;15(1):46-58. [Medline].
- Monteleone GP Jr. Stress fractures in the athlete. Orthop Clin North Am. Jul 1995;26(3):423-32. [Medline].
- Deutsch AL, Coel MN, Mink JH. Imaging of stress injuries to bone. Radiography, scintigraphy, and MR imaging. Clin Sports Med. Apr 1997;16(2):275-90. [Medline].
- Kiuru MJ, Pihlajamaki HK, Hietanen HJ, Ahovuo JA. MR imaging, bone scintigraphy, and radiography in bone stress injuries of the pelvis and the lower extremity. Acta Radiol. Mar 2002;43(2):207-12. [Medline].
- Spitz DJ, Newberg AH. Imaging of stress fractures in the athlete. Radiol Clin North Am. Mar 2002;40(2):313-31. [Medline].
- Weinfeld SB, Haddad SL, Myerson MS. Metatarsal stress fractures. Clin Sports Med. Apr 1997;16(2):319-38. [Medline].
- Bennell KL, Brukner PD. Epidemiology and site specificity of stress fractures. Clin Sports Med. Apr 1997;16(2):179-96. [Medline].
- Brukner P, Bradshaw C, Bennell K. Managing common stress fractures: let risk level guide management. Phys Sports Med. 1998;26(8):39-47.
- Burr DB. Bone, exercise, and stress fractures. Exerc Sport Sci Rev. 1997;25:171-94. [Medline].
- Chen RC, Shia DS, Kamath GV, Thomas AB, Wright RW. Troublesome stress fractures of the foot and ankle. Sports Med Arthrosc. Dec 2006;14(4):246-51. [Medline].
- Chuckpaiwong B, Cook C, Pietrobon R, Nunley JA. Second metatarsal stress fracture in sport: comparative risk factors between proximal and non-proximal locations. Br J Sports Med. Aug 2007;41(8):510-4. [Medline].
- Coady CM, Micheli LJ. Stress fractures in the pediatric athlete. Clin Sports Med. Apr 1997;16(2):225-38. [Medline].
- Fredericson M, Jennings F, Beaulieu C, Matheson GO. Stress fractures in athletes. Top Magn Reson Imaging. Oct 2006;17(5):309-25. [Medline].
- Guettler JH, Ruskan GJ, Bytomski JR, et al. Fifth metatarsal stress fractures in elite basketball players: evaluation of forces acting on the fifth metatarsal. Am J Orthop. Nov 2006;35(11):532-6. [Medline].
- Heaslet MW, Kanda-Mehtani SL. Return-to-activity levels in 96 athletes with stress fractures of the foot, ankle, and leg: a retrospective analysis. J Am Podiatr Med Assoc. Jan-Feb 2007;97(1):81-4. [Medline].
- Knapp TP, Garrett WE Jr. Stress fractures: general concepts. Clin Sports Med. Apr 1997;16(2):339-56. [Medline].
- Nagel A, Fernholz F, Kibele C, Rosenbaum D. Long distance running increases plantar pressures beneath the metatarsal heads: a barefoot walking investigation of 200 marathon runners. Gait Posture. Feb 2 2007;epub ahead of print. [Medline].
- Queen RM, Crowder TT, Johnson H, Ozumba D, Toth AP. Treatment of metatarsal stress fractures: case reports. Foot Ankle Int. Apr 2007;28(4):506-10. [Medline].
- Quill GE Jr. Fractures of the proximal fifth metatarsal. Orthop Clin North Am. Apr 1995;26(2):353-61. [Medline].
- Sammarco GJ. The Jones fracture. Instr Course Lect. 1993;42:201-5. [Medline].
- Torg JS, Balduini FC, Zelko RR, et al. Fractures of the base of the fifth metatarsal distal to the tuberosity. Classification and guidelines for non-surgical and surgical management. J Bone Joint Surg Am. Feb 1984;66(2):209-14. [Medline]. [Full Text].
Metatarsal Stress Fracture excerpt Article Last Updated: Sep 26, 2007
|